Because of the high recurrence rates following electrical cardioversion and high morbidity in AF patients there is a need to explore prediction models for AF recurrence following ECV. Previous studies have primarily focused on high-sensitivity CRP (hsCRP), CRP, and IL-6, while other inflammatory indexes and gene scores might hold greater value. This prospective cohort study is planning to include 182 patients with persistent atrial fibrillation, planned for electrical cardioversion, and \>18 years at two medium-sized hospitals in Sweden. Blood samples will be collected prior to electrical cardioversion and at 7-, 30-, 90-, and 180-days follow-up. Atrial fibrillation recurrence will be evaluated at follow-up or upon patient request and diagnosed with 12-lead ECG. An interim analysis will be conducted after more than 80 patients have been included. If the results from univariate and/or multivariable logistic regression on inflammatory markers and genetic expression regarding atrial fibrillation recurrence are significant, the study will be concluded.
Study Type
OBSERVATIONAL
Enrollment
182
Blood sampling
Medical department
Jönköping, Småland, Sweden
RECRUITINGCardiology Clinic
Norrköping, Östergötland County, Sweden
RECRUITINGRecurrence of AF
Recurrence of atrial fibrillation or atrial flutter recorded on 12-lead ECG or through pacemaker interpretation
Time frame: During follow-up (post ECV, day 7, 30, 90, and 180)
Fluctuations of biomarkers and gene expression during follow-up
Change in biomarker level or expression of gene expressions during follow-up.
Time frame: During follow-up (post ECV, day 7, 30, 90, and 180)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.